GNT Pharmaceuticals, Inc. — Form D

GNT Pharmaceuticals, Inc. of LOUISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-03. The offering totals $150K. Industry: Pharmaceuticals.

Offering

• Filed: 2025-03-03
• Form: D
• Accession: 0002057459-25-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $150K
• Remaining: $150K
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-539593

Issuer

• Name: GNT Pharmaceuticals, Inc.
• CIK: 0002057459
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 3711 QUAIL HOLLOW COURT, LOUISVILLE, KY, 40241
• Phone: 502-894-0295

Officers, directors & promoters (7)

More

• CIK 2057459 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search